Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Li, Xinyuan ^a   Fang, Pu ^a   Mai, Jietang ^a   Choi, Eric T ^a   Wang, Hong ^a   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory diseases; Mitochondria; ROS

Indexed keywords

CATALASE; CELL NUCLEUS DNA; CRYOPYRIN; CYTOCHROME C OXIDASE; CYTOKINE; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOCHONDRIAL DNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RESVERATROL; SIRTUIN 1; STAT3 PROTEIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR; UBIQUINOL CYTOCHROME C REDUCTASE; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT;

AEROBIC GLYCOLYSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CYTOKINE RELEASE; DENDRITIC CELL; ELECTRON SPIN RESONANCE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATORY DISEASE; MACROPHAGE; MALIGNANT NEOPLASM; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOPHAGY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; OXYGEN CONCENTRATION; REVIEW; SMOOTH MUSCLE CELL; ANIMAL; DRUG EFFECT; INFLAMMATION; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; INFLAMMATION; MITOCHONDRIA; NEOPLASMS; REACTIVE OXYGEN SPECIES;

MLCS; MLOWN;

EID: 84874122566     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-19     Document Type: Review

References (173)

1. Winterbourn CC: Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 2008, 4:278-286.
2. Block K, Gorin Y: Aiding and abetting roles of NOX oxidases in cellular transformation. Nat Rev Cancer 2012, 12:627-637.
3. West AP, Shadel GS, Ghosh S: Mitochondria in innate immune responses. Nat Rev Immunol 2011, 11:389-402.
4. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A: Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A 2009, 106:2770-2775.
5. Zhou R, Yazdi AS, Menu P, Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature 2010, 469:221-225.
6. Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, Sack MN, Kastner DL, Siegel RM: Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 2011, 208:519-533.
7. Nakashima Y, Chen YX, Kinukawa N, Sueishi K: Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age. Virchows Arch 2002, 441:279-288.
8. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF: Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. Jama 1999, 281:727-735.
9. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
10. Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
11. Madamanchi NR, Runge MS: Mitochondrial dysfunction in atherosclerosis. Circ Res 2007, 100:460-473.
12. Zhang DX, Gutterman DD: Mitochondrial reactive oxygen speciesmediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 2007, 292:H2023-H2031.
13. Handy DE, Loscalzo J: Redox regulation of mitochondrial function. Antioxid Redox Signal 2012, 16:1323-1367.
14. Tschopp J: Mitochondria: Sovereign of inflammation? Eur J Immunol 2011, 41:1196-1202.
15. Aon MA, Cortassa S, O'Rourke B: Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 2010, 1797:865-877.
16. Han D, Canali R, Rettori D, Kaplowitz N: Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol Pharmacol 2003, 64:1136-1144.
17. Cadenas E, Davies KJ: Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000, 29:222-230.
18. Okado-Matsumoto A, Fridovich I: Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria. J Biol Chem 2001, 276:38388-38393.
19. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, et al: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995, 11:376-381.
20. Ohashi M, Runge MS, Faraci FM, Heistad DD: MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2006, 26:2331-2336.
21. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA: Detection of catalase in rat heart mitochondria. J Biol Chem 1991, 266:22028-22034.
22. Yang H, Roberts LJ, Shi MJ, Zhou LC, Ballard BR, Richardson A, Guo ZM: Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 2004, 95:1075-1081.
23. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, et al: Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
24. Torzewski M, Ochsenhirt V, Kleschyov AL, Oelze M, Daiber A, Li H, Rossmann H, Tsimikas S, Reifenberg K, Cheng F, et al: Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:850-857.
25. Rhee SG, Chae HZ, Kim K: Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005, 38:1543-1552.
26. Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara T, et al: Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2006, 113:1779-1786.
27. Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano FJ, Shadel G, et al: Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol 2007, 170:1108-1120.
28. He M, Cai J, Go YM, Johnson JM, Martin WD, Hansen JM, Jones DP: Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition. Toxicol Sci 2008, 105:44-50.
29. Sokol RJ, McKim JM Jr, Goff MC, Ruyle SZ, Devereaux MW, Han D, Packer L, Everson G: Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 1998, 114:164-174.
30. Gilgun-Sherki Y, Melamed E, Offen D: Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001, 40:959-975.
31. Murphy MP, Smith RA: Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007, 47:629-656.
32. Smith RA, Porteous CM, Coulter CV, Murphy MP: Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999, 263:709-716.
33. Davidson SM: Endothelial mitochondria and heart disease. Cardiovasc Res 2010, 88:58-66.
34. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP: Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 2001, 276:4588-4596.
35. Ballinger SW: Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005, 38:1278-1295.
36. Toime LJ, Brand MD: Uncoupling protein-3 lowers reactive oxygen species production in isolated mitochondria. Free Radic Biol Med 2010, 49:606-611.
37. Brennan JP, Southworth R, Medina RA, Davidson SM, Duchen MR, Shattock MJ: Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res 2006, 72:313-321.
38. Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS, Lee WJ, Koh EH, Song KH, et al: Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 2005, 96:1200-1207.
39. Chance B, Williams GR: Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 1955, 217:409-427.
40. Andriantsitohaina R, Duluc L, Garcia-Rodriguez JC: Gil-del Valle L, Guevara-Garcia M, Simard G, Soleti R, Su DF, Velasquez-Perez L, Wilson JX, Laher I: Systems biology of antioxidants. Clin Sci (Lond) 2012, 123:173-192.
41. Stuehr DJ: Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 1997, 37:339-359.
42. Ghafourifar P, Richter C: Nitric oxide synthase activity in mitochondria. FEBS Lett 1997, 418:291-296.
43. Shiva S: Mitochondria as metabolizers and targets of nitrite. Nitric Oxide 2010, 22:64-74.
44. Feissner RF, Skalska J, Gaum WE, Sheu SS: Crosstalk signaling between mitochondrial Ca2+ and ROS. Front Biosci 2009, 14:1197-1218.
45. Peng TI, Jou MJ: Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 2010, 1201:183-188.
46. Turrens JF, Freeman BA, Levitt JG, Crapo JD: The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch Biochem Biophys 1982, 217:401-410.
47. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT: Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005, 1:401-408.
48. McLeod CJ, Aziz A, Hoyt RF Jr, McCoy JP Jr, Sack MN: Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem 2005, 280:33470-33476.
49. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, et al: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
50. Okamoto K, Kondo-Okamoto N: Mitochondria and autophagy: critical interplay between the two homeostats. Biochim Biophys Acta 1820, 2012:595-600.
51. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK: Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008, 294:H570-H578.
52. Pangare M, Makino A: Mitochondrial function in vascular endothelial cell in diabetes. J Smooth Muscle Res 2012, 48:1-26.
53. Szczepanek K, Lesnefsky EJ, Larner AC: Multi-tasking: nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol 2012, 22:429-437.
54. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, et al: Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
55. Semenza GL: Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 1813, 2011:1263-1268.
56. Sauve AA: Sirtuin chemical mechanisms. Biochim Biophys Acta 1804, 2010:1591-1603.
57. Gertz M, Steegborn C: Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia. Biochim Biophys Acta 1804, 2009:1658-1665.
58. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei YS, Cai H, Liu DP, Liang CC: Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 2008, 80:191-199.
59. Orimo M, Minamino T, Miyauchi H, Tateno K, Okada S, Moriya J, Komuro I: Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 2009, 29:889-894.
60. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
61. Khanduja KL, Bhardwaj A, Kaushik G: Resveratrol inhibits Nnitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. J Nutr Sci Vitaminol (Tokyo) 2004, 50:61-65.
62. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
63. Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, Booth T: Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Res 2005, 67:155-162.
64. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
65. Chu LM, Lassaletta AD, Robich MP, Sellke FW: Resveratrol in the prevention and treatment of coronary artery disease. Curr Atheroscler Rep 2011, 13:439-446.
66. Corda S, Laplace C, Vicaut E, Duranteau J: Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 2001, 24:762-768.
67. Hawkins BJ, Solt LA, Chowdhury I, Kazi AS, Abid MR, Aird WC, May MJ, Foskett JK, Madesh M: G protein-coupled receptor Ca2 + -linked mitochondrial reactive oxygen species are essential for endothelial/leukocyte adherence. Mol Cell Biol 2007, 27:7582-7593.
68. Rowlands DJ, Islam MN, Das SR, Huertas A, Quadri SK, Horiuchi K, Inamdar N, Emin MT, Lindert J, Ten VS, et al: Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels. J Clin Invest 2011, 121:1986-1999.
69. Ouchi N, Parker JL, Lugus JJ, Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
70. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001, 276:25096-25100.
71. Chen C, Jiang J, Lu JM, Chai H, Wang X, Lin PH, Yao Q: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 2010, 299:H193-H201.
72. van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, Pearce EJ, Pearce EL: Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012, 36:68-78.
73. Quinn LS, Anderson BG, Conner JD, Wolden-Hanson T: IL-15 Overexpression Promotes Endurance, Oxidative Energy Metabolism, and Muscle PPARdelta, SIRT1, PGC-1alpha, and PGC-1beta Expression in Male Mice. Endocrinology 2012.
74. Doughan AK, Harrison DG, Dikalov SI: Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008, 102:488-496.
75. Baudry N, Laemmel E, Vicaut E: In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: involvement of xanthine oxidase and mitochondria. Am J Physiol Heart Circ Physiol 2008, 294:H821-H828.
76. Ceylan-Isik AF, Guo KK, Carlson EC, Privratsky JR, Liao SJ, Cai L, Chen AF, Ren J: Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. Hypertension 2009, 53:1023-1031.
77. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK: NAD(P)H oxidasederived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 2002, 4:899-914.
78. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI: Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 2010, 107:106-116.
79. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, et al: Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
80. Gertz M, Fischer F, Wolters D, Steegborn C: Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc Natl Acad Sci U S A 2008, 105:5705-5709.
81. Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, Luscher TF: Oxidized low-density lipoprotein activates p66Shc via lectinlike oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol 2011, 31:2090-2097.
82. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P: Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A 2003, 100:2112-2116.
83. Finkel T: Signal transduction by mitochondrial oxidants. J Biol Chem 2012, 287:4434-4440.
84. Finkel T: Signal transduction by reactive oxygen species. J Cell Biol 2011, 194:7-15.
85. Fomenko DE, Xing W, Adair BM, Thomas DJ, Gladyshev VN: Highthroughput identification of catalytic redox-active cysteine residues. Science 2007, 315:387-389.
86. Weerapana E, Wang C, Simon GM, Richter F, Khare S, Dillon MB, Bachovchin DA, Mowen K, Baker D, Cravatt BF: Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 2010, 468:790-795.
87. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995, 92:5510-5514.
88. Tello D, Balsa E, Acosta-Iborra B, Fuertes-Yebra E, Elorza A, Ordonez A, Corral-Escariz M, Soro I, Lopez-Bernardo E, Perales-Clemente E, et al: Induction of the mitochondrial NDUFA4L2 protein by HIF-1alpha decreases oxygen consumption by inhibiting Complex I activity. Cell Metab 2011, 14:768-779.
89. Gross O, Thomas CJ, Guarda G, Tschopp J: The inflammasome: an integrated view. Immunol Rev 2011, 243:136-151.
90. Strowig T, Henao-Mejia J, Elinav E, Flavell R: Inflammasomes in health and disease. Nature 2012, 481:278-286.
91. Lamkanfi M: Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011, 11:213-220.
92. Zitvogel L, Kepp O, Galluzzi L, Kroemer G: Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 2012, 13:343-351.
93. Kepp O, Galluzzi L, Zitvogel L, Kroemer G: Pyroptosis - a cell death modality of its kind? Eur J Immunol 2010, 40:627-630.
94. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, Hornung V: Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 2011, 187:613-617.
95. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, Yang XF: Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 2009, 22:311-322.
96. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661.
97. Naik E, Dixit VM: Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 2011, 208:417-420.
98. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB: Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000, 20:645-651.
99. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995, 182:367-377.
100. Riedl SJ, Salvesen GS: The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007, 8:405-413.
101. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z: Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. Embo J 2007, 26:1749-1760.
102. Zmijewski JW, Moellering DR, Le Goffe C, Landar A, Ramachandran A, Darley-Usmar VM: Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol 2005, 289:H852-H861.
103. Landar A, Zmijewski JW, Dickinson DA, Le Goffe C, Johnson MS, Milne GL, Zanoni G, Vidari G, Morrow JD, Darley-Usmar VM: Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am J Physiol Heart Circ Physiol 2006, 290:H1777-H1787.
104. Watanabe N, Zmijewski JW, Takabe W, Umezu-Goto M, Le Goffe C, Sekine A, Landar A, Watanabe A, Aoki J, Arai H, et al: Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 2006, 168:1737-1748.
105. Smith RA, Hartley RC, Murphy MP: Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal 2011, 15:3021-3038.
106. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, Pacher P: Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2007, 2:2295-2301.
107. Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ 2nd, Ischiropoulos H: Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 2012, 52:1-6.
108. Dickinson BC, Chang CJ: A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc 2008, 130:9638-9639.
109. Dickinson BC, Srikun D, Chang CJ: Mitochondrial-targeted fluorescent probes for reactive oxygen species. Curr Opin Chem Biol 2010, 14:50-56.
110. Koide Y, Urano Y, Kenmoku S, Kojima H, Nagano T: Design and synthesis of fluorescent probes for selective detection of highly reactive oxygen species in mitochondria of living cells. J Am Chem Soc 2007, 129:10324-10325.
111. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
112. Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC: Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res 2003, 92:371-377.
113. Pearlstein DP, Ali MH, Mungai PT, Hynes KL, Gewertz BL, Schumacker PT: Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol 2002, 22:566-573.
114. Schafer M, Schafer C, Ewald N, Piper HM, Noll T: Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res 2003, 92:1010-1015.
115. Moreira ES, Brasch NE, Yun J: Vitamin B12 protects against superoxideinduced cell injury in human aortic endothelial cells. Free Radic Biol Med 2011, 51:876-883.
116. Smith RA, Porteous CM, Gane AM, Murphy MP: Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A 2003, 100:5407-5412.
117. Rodriguez-Cuenca S, Cocheme HM, Logan A, Abakumova I, Prime TA, Rose C, Vidal-Puig A, Smith AC, Rubinsztein DC, Fearnley IM, et al: Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 2010, 48:161-172.
118. Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cocheme HM, Murphy MP, Dominiczak AF: Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009, 54:322-328.
119. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA: Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. Faseb J 2005, 19:1088-1095.
120. Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, Agarwal A, Zinn KR, Murphy MP, Kalyanaraman B, Darley-Usmar V: Prevention of diabetic nephropathy in Ins2(+/)(-)(AkitaJ) mice by the mitochondriatargeted therapy MitoQ. Biochem J 2010, 432:9-19.
121. Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF: The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 2008, 45:1559-1565.
122. Supinski GS, Murphy MP, Callahan LA: MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1095-R1102.
123. Esplugues JV, Rocha M, Nunez C, Bosca I, Ibiza S, Herance JR, Ortega A, Serrador JM, D'Ocon P, Victor VM: Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 2006, 99:1067-1075.
124. Kuznetsov AV, Kehrer I, Kozlov AV, Haller M, Redl H, Hermann M, Grimm M, Troppmair J: Mitochondrial ROS production under cellular stress: comparison of different detection methods. Anal Bioanal Chem 2011, 400:2383-2390.
125. Hardy M, Chalier F, Ouari O, Finet JP, Rockenbauer A, Kalyanaraman B, Tordo P: Mito-DEPMPO synthesized from a novel NH2-reactive DEPMPO spin trap: a new and improved trap for the detection of superoxide. Chem Commun (Camb) 2007:1083-1085.
126. Quintero M, Colombo SL, Godfrey A, Moncada S: Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci U S A 2006, 103:5379-5384.
127. Blouin A, Bolender RP, Weibel ER: Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 1977, 72:441-455.
128. Dranka BP, Hill BG, Darley-Usmar VM: Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic Biol Med 2010, 48:905-914.
129. Widlansky ME, Gutterman DD: Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal 2011, 15:1517-1530.
130. Wang Y, Zang QS, Liu Z, Wu Q, Maass D, Dulan G, Shaul PW, Melito L, Frantz DE, Kilgore JA, et al: Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am J Physiol Cell Physiol 2011, 301:C695-C704.
131. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD: Mitochondrial sources of H2O2 generation play a key role in flowmediated dilation in human coronary resistance arteries. Circ Res 2003, 93:573-580.
132. Weber C, Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011, 17:1410-1422.
133. Roy Chowdhury SK, Sangle GV, Xie X, Stelmack GL, Halayko AJ, Shen GX: Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am J Physiol Endocrinol Metab 2010, 298:E89-E98.
134. Takabe W, Li R, Ai L, Yu F, Berliner JA, Hsiai TK: Oxidized low-density lipoprotein-activated c-Jun NH2-terminal kinase regulates manganese superoxide dismutase ubiquitination: implication for mitochondrial redox status and apoptosis. Arterioscler Thromb Vasc Biol 2010, 30:436-441.
135. Libby P, Ridker PM, Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
136. Matsumoto T, Kobayashi T, Kamata K: Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007, 14:3209-3220.
137. Haffner SJ, Cassells H: Hyperglycemia as a cardiovascular risk factor. Am J Med 2003, 115(Suppl 8A):6S-11S.
138. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gero D, Szoleczky P, Chang T, Zhou Z, Wu L, et al: Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A 2011, 108:13829-13834.
139. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P, Csiszar A: Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2009, 297:H1876-H1881.
140. Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Drel VR, Obrosova IG, Pacher P: Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 2007, 293:H610-H619.
141. Zheng Z, Chen H, Wang H, Ke B, Zheng B, Li Q, Li P, Su L, Gu Q, Xu X: Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha. Diabetes 2010, 59:2315-2325.
142. Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, Gutterman DD, Widlansky ME: Acute Exposure to Low Glucose Rapidly Induces Endothelial Dysfunction and Mitochondrial Oxidative Stress: Role for AMP Kinase. Arterioscler Thromb Vasc Biol 2012, 32:712-720.
143. Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 2005, 46:932-936.
144. Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-737.
145. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S: TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
146. Del Prete A, Zaccagnino P, Di Paola M, Saltarella M, Oliveros Celis C, Nico B, Santoro G, Lorusso M: Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic Biol Med 2008, 44:1443-1451.
147. Gerthoffer WT: Mechanisms of vascular smooth muscle cell migration. Circ Res 2007, 100:607-621.
148. Lee SJ, Seo KW, Yun MR, Bae SS, Lee WS, Hong KW, Kim CD: 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NFkappaB signaling pathways. Free Radic Biol Med 2008, 45:1487-1492.
149. Bailey SR, Mitra S, Flavahan S, Flavahan NA: Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 2005, 289:H243-H250.
150. Sato H, Sato M, Kanai H, Uchiyama T, Iso T, Ohyama Y, Sakamoto H, Tamura J, Nagai R, Kurabayashi M: Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc Res 2005, 67:714-722.
151. Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
152. Koppenol WH, Bounds PL, Dang CV: Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011, 11:325-337.
153. Wellen KE, Thompson CB: Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell 2010, 40:323-332.
154. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC: The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
155. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, et al: Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
156. Hamanaka RB, Chandel NS: Cell biology. Warburg effect and redox balance. Science 2011, 334:1219-1220.
157. Harrison DG, Gongora MC: Oxidative stress and hypertension. Med Clin North Am 2009, 93:621-635.
158. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003, 144:2179-2183.
159. Widder JD, Fraccarollo D, Galuppo P, Hansen JM, Jones DP, Ertl G, Bauersachs J: Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 2009, 54:338-344.
160. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, et al: Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
161. Fujimoto H, Taguchi J, Imai Y, Ayabe S, Hashimoto H, Kobayashi H, Ogasawara K, Aizawa T, Yamakado M, Nagai R, Ohno M: Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur Heart J 2008, 29:1267-1274.
162. Ciccone S, Maiani E, Bellusci G, Diederich M, Gonfloni S: Parkinson'S disease: a complex interplay of mitochondrial DNA alterations and oxidative stress. Int J Mol Sci 2013, 14:2388-2409.
163. Xie H, Lev D, Gong Y, Wang S, Pollock RE, Wu X, Gu J: Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis 2013.
164. Krzywanski DM, Moellering DR, Fetterman JL, Dunham-Snary KJ, Sammy MJ, Ballinger SW: The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics. Lab Invest 2011, 91:1122-1135.
165. Gilgun-Sherki Y, Melamed E, Offen D: The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004, 251:261-268.
166. Filippin LI, Vercelino R, Marroni NP, Xavier RM: Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008, 152:415-422.
167. Burek CL, Rose NR: Autoimmune thyroiditis and ROS. Autoimmun Rev 2008, 7:530-537.
168. Chen J, Gusdon AM, Thayer TC, Mathews CE: Role of increased ROS dissipation in prevention of T1D. Ann N Y Acad Sci 2008, 1150:157-166.
169. Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ, Chae JJ, Ettinger R, de Koning HD, Cruz AC, et al: Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci U S A 2010, 107:9801-9806.
170. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ: Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003, 361:2017-2023.
171. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama 2007, 297:842-857.
172. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM: Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Jama 2008, 300:2123-2133.
173. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE: A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610-1618.